XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance

癌症研究 生物 突变体 拓扑异构酶 癌症 伊立替康 DNA损伤 结直肠癌 突变 癌细胞 拓扑异构酶抑制剂 子宫内膜癌 合成致死 分子生物学 基因 遗传学 DNA
作者
Tulasigeri M. Totiger,Wannasiri Chiraphapphaiboon,Yasmine Baca,Sana Chaudhry,Ryan Q. Notti,Skye Montoya,Monika Chojnacka,Gabriel Gaidosh,Jumana Afaghani,Maurizio Affer,Christopher Armstrong,Paul M. Kavanaugh,Efe Karaca,Jenna Zabroski,M. H. Lewis,Alyssa Maye,Jacob Jahn,Rajesh K. Soni,Daniel Bilbao,Phil Walker
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:85 (17): 3219-3233
标识
DOI:10.1158/0008-5472.can-24-3112
摘要

Abstract Exportin-1 (XPO1) is a nuclear export receptor that is essential for cell survival. Previous genomic analyses have identified recurrent XPO1 hotspot mutations in cancer. In this study, we conducted a large-scale genomic analysis of 217,570 patients with cancer to identify and characterize XPO1 variants from real-world patient tumors. XPO1 harbored an R749Q mutation in various solid tumors, with a clear enrichment in endometrial and colorectal cancers, and XPO1R749Q mutations significantly co-occurred with polymerase epsilon (POLE) mutations. Analysis of isogenic colon cancer cell lines revealed that XPO1R749Q localized more in the cytoplasm than wild-type XPO1, with enhanced export of a large number of proteins. Structural modeling of XPO1R749Q suggested an increase in RanGTP affinity, which is consistent with enhanced protein export. A compound library screen using more than 200 FDA-approved anticancer drugs indicated a general trend toward chemoresistance, specifically to topoisomerase I inhibition, in XPO1R749Q-mutant cells. Mechanistically, XPO1R749Q-mutant cells exhibited an enhanced DNA damage response via replication protein A phosphorylation in response to topoisomerase I inhibition. Combining XPO1 and topoisomerase I inhibitors reduced DNA damage–induced replication protein A phosphorylation and mediated synergistic antitumor effects in cells harboring the XPO1R749Q mutation. Finally, the combination of selinexor and irinotecan overcame chemotherapeutic resistance in xenograft mouse models, prolonging survival. These findings suggest that XPO1 alterations in cancer are selected in POLE-mutant tumors and may confer resistance to DNA-damaging chemotherapies, which have implications for patients with tumors bearing XPO1R749Q and for XPO1 inhibitor development in cancer. Significance: XPO1 R749Q is a recurrent mutation in cancer that is associated with POLE mutations and corresponds to topoisomerase I inhibitor resistance, which can be overcome by addition of the XPO1 inhibitor selinexor.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
JK157完成签到,获得积分10
刚刚
luoll发布了新的文献求助10
刚刚
刚刚
马敬丽发布了新的文献求助10
1秒前
yuuuuu发布了新的文献求助10
1秒前
1秒前
Orange的应助被PSL采纳,获得10
2秒前
2秒前
2秒前
无花果的应助被胡尾声采纳,获得10
2秒前
aaa发布了新的文献求助10
2秒前
2秒前
研友_VZG7GZ的应助被狂野的含烟采纳,获得10
3秒前
李乐安发布了新的文献求助30
4秒前
Zyyy1637完成签到,获得积分10
4秒前
大力水手爱吃菠菜完成签到,获得积分10
5秒前
科研通AI2S的应助被Lily采纳,获得10
5秒前
SciGPT的应助被鸭梨山大33采纳,获得10
5秒前
5秒前
Owen的应助被神宝嘎li采纳,获得10
5秒前
ll发布了新的文献求助10
6秒前
6秒前
HongY发布了新的文献求助10
6秒前
wjw发布了新的文献求助10
6秒前
zzk发布了新的文献求助10
7秒前
wanci的应助被从容的采纳,获得10
7秒前
张兵完成签到,获得积分10
8秒前
在水一方的应助被笑着流泪采纳,获得10
8秒前
随机昵称过于可爱完成签到,获得积分10
8秒前
斯文败类的应助被arpege采纳,获得10
9秒前
田様的应助被坚强孤容采纳,获得10
9秒前
9秒前
FashionBoy的应助被KevinL采纳,获得10
9秒前
朴实的曼云完成签到,获得积分10
9秒前
lm发布了新的文献求助10
10秒前
sagitar的应助被西原的橙果采纳,获得60
10秒前
11秒前
虹虹完成签到 ,获得积分10
11秒前
11秒前
zeena完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572482
关于积分的说明 21825940
捐赠科研通 7780074
什么是DOI,文献DOI怎么找? 3433945
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480166